Pharma Deploys Small Army Of Advocates To Fight Against The Budget Deal That Reportedly Contains Pricing Reforms

It isn’t clear yet what kind of policies Congress is considering that could hurt the pharmaceutical industry’s bottom line, but it has been reported that the reforms could cost the industry $115 billion. In other pharmaceutical news: the CVS-Aetna merger, hep C treatment and prisoners, biotech, and President Donald Trump's drug pricing strategy.

from Kaiser Health News https://ift.tt/2GocrBF